Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
ALKS |
|
sNDA Submission |
Other |
None |
|
H2 2016
|
CHRS |
|
Phase 3 Results |
Other |
None |
|
H2 2016
|
CRMD |
|
Phase 3 Results |
Other |
Fast Track |
|
H2 2016
|
GWPH |
|
Phase 3 Results |
Neurology |
Fast Track, Orphan Drug |
|
H2 2016
|
HZNP |
|
Phase 3 Results |
Neurology |
Fast Track, Orphan Drug |
|
Q4 2016
|
ITEK |
|
Phase 3 Results |
Opthamology |
None |
|
H2 2016
|
OPK |
|
Phase 3 Results |
Endocrine |
None |
|
Q4 2016
|
OTIC |
|
Phase 3 Results |
Other |
None |
|
Q4 2017
|
ESPR |
|
Phase 3 Results |
Other |
None |
|
H2 2017
|
EXEL |
|
Phase 3 Results |
Oncology |
None |
|